INNOVATE BIOPHARMACEUTICALS, INC. Business Finance Contracts & Agreements

53 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to the Forbearance Agreement
Forbearance Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2023
Amendment No. 1 to the Forbearance Agreement, dated May 18, 2023
Forbearance Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2023
Forbearance Agreement, dated April 26, 2023
Forbearance Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2023
Form of Securities Purchase Agreement
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2023
Form of Placement Agent Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Form of Pre-Funded Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Form of Common Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2023
First Amendment to the Amended and Restated Senior Secured Convertible Note Due 2025
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2023
Form of Amended and Restated Senior Secured Convertible Note
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2022
Form of Senior Secured Convertible Note
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2022
Form of Securities Purchase Agreement
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
Form of 9 Meters Biopharma, Inc. Notice of Stock Option Grant and Award Agreement
Stock Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2022
Asset Purchase Agreement between 9 Meters Biopharma, Inc. and Lobesity, LLC, dated July 19, 2021
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2021
Underwriting Agreement, dated March 30, 2021, by and between 9 Meters Biopharma, Inc., Citigroup Global Markets Inc., William Blair & Company, L.L.C., and Truist Securities, Inc
Underwriting Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2021
Underwriting Agreement, dated December 11, 2020, by and between 9 Meters Biopharma, Inc., William Blair & Company, L.L.C., and Truist Securities, Inc., as representatives of the...
Underwriting Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Registration Rights Agreement, dated April 29, 2020, between Innovate Biopharmaceuticals, Inc. and the investors named therein
Registration Rights Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
Securities Purchase Agreement, dated April 29, 2020, between Innovate Biopharmaceuticals, Inc. and the investors named therein
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
Form of Series A Convertible Preferred Stock Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Form of Amendment to Short-term Common Stock Purchase Warrant, dated February 6, 2020
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Note Purchase Agreement, dated January 10, 2020, by and between the Company and Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2020
Note issued to Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2020
Form of Exchange Agreement
Exchange Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2019
Form of Securities Purchase Agreement, dated April 29, 2019, by and among the Company and the purchasers party thereto
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Form of Placement Agent Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2019
Form of Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2019
Amendment, dated April 25, 2019, to Securities Purchase Agreement, dated as of March 17, 2019, by and between the Company and the Purchasers party thereto
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Form of Long-Term Warrant (included in Exhibit 10.1)
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Note Purchase Agreement, dated March 8, 2019, by and between the Company and Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2019
Note issued to Atlas Sciences, LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
UT
2019
Option to Purchase Senior Convertible Note, by and between the Company and Gustavia Capital Partners LLC and/or its affiliates dated as of January 7, 2019
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Common Stock Sales Agreement by and among the Company and H.C. Wainwright & Co., LLC and Ladenburg Thalmann & Co. Inc. dated as of October 26, 2018
Stock Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Senior Convertible Note with Gustavia Capital Partners LLC
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Amendment and Exchange Agreement by and between the Company and Gustavia Capital Partners LLC, dated as of October 4, 2018
Exchange Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2018
Asset Purchase Agreement, dated December 23, 2014, between Innovate Biopharmaceuticals Inc. (now IB Pharmaceuticals Inc.) and Repligen Corporation
Purchase Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
DE
2018
Form of Share Certificate
Share Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2018
Senior Note dated January 29, 2018
Note Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Form of Warrant
Warrant Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2018
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2017
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2017
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
INNOVATE BIOPHARMACEUTICALS, INC.
2016